Interview with Craig Moore, Director, Hahn Healthcare
Can you outline the significance of the current PBS to the industry and in particular the impact it has on service providers to the industry such as Hahn? As service…
Address: Level 7, 50 Berry Street
North Sydney NSW 2060
Tel: 02 9959 5533
Web: http://www.hahnhealthcare.com.au/default.aspx
Hahn Healthcare combines innovative solutions and world-class services with market insight to create value in your business.
Hahn Healthcare offers clients access to: the highest quality people, industry leading solutions, innovative services, and new market opportunities.
Founded in 1994, Hahn Healthcare is a trusted partner with a reputation for excellence.
Innovative solutions. Market insight. Trusted Partnerships.
As a market leader, Hahn Healthcare is a trusted partner of key decision makers in the Australian pharmaceutical and medical device industries.
We are uniquely positioned to identify partner organisations and market opportunities for global healthcare products, including pharmaceutical and medical devices.
Our team partners with international companies to deliver global solutions locally. We provide strategic advice based on deep industry knowledge and create an access point to the Australian market.
Hahn Healthcare helps international companies reduce risk, manage regulatory requirements and create new revenue streams by facilitating the delivery of global solutions to the Australian marketplace.
Hahn Healthcare is committed to excellence. We build partnerships based on integrity, mutual respect and trust. We are transparent, accountable and operate according to the highest professional standards.
Can you outline the significance of the current PBS to the industry and in particular the impact it has on service providers to the industry such as Hahn? As service…
Pharmaceutical policy issues played a major role in Australia’s recent national election. Shawview Consulting’s Brendan Shaw outlines the medicines issues that came under scrutiny during the campaign. It was the…
Writing in April edition of DIA’s Global Forum magazine, the University of New South Wales’s Richard Day looks at Australia’s National Medicines Policy (NMP) and how it is being reshaped…
Writing in the January edition of DIA’s Global Forum magazine, Julia Chan, David Liew, Jana Stojanova, and Chris McMaster of Austin Health, Melbourne and St. Vincent’s Hospital Sydney outline how…
In conversation in the November issue of DIA’s Global Forum magazine, Australian Pharmaceutical medical and scientific Professionals Association (APPA) Past President David Grolman highlights the contributions that Australia is already…
Regular PharmaBoardroom contributor Brendan Shaw outlines how his home country of Australia has so far successfully managed to avoid the worst of the COVID-19 pandemic, providing opportunities for the life…
In an exclusive new podcast, DIA Global Forum Australia/New Zealand Regional Editor Richard Day (University of New South Wales, Medicine, St. Vincent’s Hospital) and John Skeritt, Head of Australia’s Therapeutic Goods Administration (TGA),…
Janssen Australia & New Zealand’s Bruce Goodwin argues that greater adoption of patient-centric practices is beneficial to patients, companies and healthcare systems as a whole. Goodwin also gives his five…
Can you start by giving our readers a brief overview of the company’s history here and your most notable achievements? Initially the company was founded as a small distributor of…
Would you begin by outlining the role & importance of George Clinical within the George Institute, highlighting recent milestones & achievements? George Clinical is an important division of the Institute,…
Would you begin by giving an introduction to our international readers of the institute, highlighting recent milestones & achievements and the current focus areas of its research activities? Broadly speaking,…
For those that are not familiar with your name, would you start by introducing yourself? After obtaining my PhD in cardiovascular physiology I moved to Boston to work at MIT…
Rare Voices Australia is a new organisation that has been established after the national rare diseases symposium in 2011. Can you please begin with giving our readers an introduction to…
See our Cookie Privacy Policy Here
